scholarly article | Q13442814 |
P2093 | author name string | Qi Chen | |
Yanhui Liu | |||
Hengguo Zhuang | |||
P2860 | cites work | Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study | Q24684767 |
Global cancer statistics, 2002 | Q27860562 | ||
Cancer statistics, 2012 | Q27860574 | ||
Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults | Q28131763 | ||
Obesity: preventing and managing the global epidemic. Report of a WHO consultation | Q29547404 | ||
Prevalence and trends in obesity among US adults, 1999-2008 | Q29547759 | ||
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies | Q29614869 | ||
Body-mass index and symptoms of gastroesophageal reflux in women | Q33245320 | ||
A population-based study of IGF axis polymorphisms and the esophageal inflammation, metaplasia, adenocarcinoma sequence | Q34022123 | ||
Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study | Q34065827 | ||
Influence of obesity on the risk of esophageal disorders | Q34190035 | ||
Body mass index, height and risk of adenocarcinoma of the oesophagus and gastric cardia: a prospective cohort study | Q34576888 | ||
Central adiposity and risk of Barrett's esophagus | Q34660127 | ||
Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia | Q34744904 | ||
Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications | Q36215395 | ||
Helicobacter pylori and esophageal cancer risk: a meta-analysis | Q36410246 | ||
Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis | Q36479652 | ||
A prospective study of BMI and risk of oesophageal and gastric adenocarcinoma | Q36597089 | ||
Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. | Q36841557 | ||
Abdominal obesity and the risk of esophageal and gastric cardia carcinomas | Q37163349 | ||
Trends in esophageal cancer and body mass index by race and gender in the state of Michigan. | Q37255726 | ||
Cigarette smoking, body mass index, gastro-esophageal reflux disease, and non-steroidal anti-inflammatory drug use and risk of subtypes of esophageal and gastric cancers by P53 overexpression | Q37305467 | ||
Adiponectin action from head to toe. | Q37801870 | ||
Continuing rapid increase in esophageal adenocarcinoma in England and Wales | Q39171596 | ||
Associations between leptin and adiponectin receptor upregulation, visceral obesity and tumour stage in oesophageal and junctional adenocarcinoma | Q39679982 | ||
Leptin stimulates the proliferation of human oesophageal adenocarcinoma cells via HB-EGF and Tgfalpha mediated transactivation of the epidermal growth factor receptor | Q39921074 | ||
Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. | Q40817530 | ||
Trends in incidence rates of adenocarcinoma of the oesophagus and gastric cardia in New Zealand, 1978-1992. | Q41215729 | ||
Endoscopic sonography in esophageal cancer | Q42146707 | ||
Cyclic estradiol treatment normalizes body weight and restores physiological patterns of spontaneous feeding and sexual receptivity in ovariectomized rats | Q44253219 | ||
Adenocarcinoma of the esophagus: role of obesity and diet | Q44476677 | ||
Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study | Q46538261 | ||
Adiponectin multimeric complexes and the metabolic syndrome trait cluster | Q46870222 | ||
Body size and composition and the risk of gastric and oesophageal adenocarcinoma | Q47357608 | ||
Height and body mass index in relation to esophageal cancer; 23-year follow-up of two million Norwegian men and women | Q47405537 | ||
Gonadal hormones determine sensitivity to central leptin and insulin | Q48603194 | ||
Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. | Q49304505 | ||
Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. | Q50537419 | ||
Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. | Q50661717 | ||
Do sex hormones play a role in the etiology of esophageal adenocarcinoma? A new hypothesis tested in a population-based cohort of prostate cancer patients. | Q50859761 | ||
Age effects and temporal trends in adenocarcinoma of the esophagus and gastric cardia (United States). | Q51937686 | ||
Obesity, metabolic syndrome and esophageal adenocarcinoma: epidemiology, etiology and new targets. | Q53255823 | ||
Relation of body mass index to cancer risk in 362,552 Swedish men. | Q53343955 | ||
Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus. | Q53387945 | ||
Adenocarcinoma of the oesophagus and gastric cardia: Male preponderance in association with obesity | Q57521964 | ||
Circulating concentrations of insulin-like growth factor I and risk of breast cancer | Q57751183 | ||
Association between body mass and adenocarcinoma of the esophagus and gastric cardia | Q58204836 | ||
Leptin binding activity changes with age: the link between leptin and puberty | Q62750339 | ||
Serum leptin levels during the menstrual cycle of healthy fertile women | Q73009037 | ||
Demographic variations in the rising incidence of esophageal adenocarcinoma in white males | Q74373937 | ||
Estrogen deficiency causes central leptin insensitivity and increased hypothalamic neuropeptide Y | Q77378685 | ||
Precedence of the shift of body-fat distribution over the change in body composition after menopause | Q80291217 | ||
Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinoma | Q80291239 | ||
The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence | Q81290009 | ||
A polymorphic variant of the insulin-like growth factor type I receptor gene modifies risk of obesity for esophageal adenocarcinoma | Q84398648 | ||
P433 | issue | 3 | |
P921 | main subject | obesity | Q12174 |
P304 | page(s) | 226-231 | |
P577 | publication date | 2012-09-01 | |
P1433 | published in | Journal of gastrointestinal oncology | Q26842467 |
P1476 | title | The association between obesity factor and esophageal caner | |
P478 | volume | 3 |
Q34595624 | AZD5363 Inhibits Inflammatory Synergy between Interleukin-17 and Insulin/Insulin-Like Growth Factor 1 |
Q92756427 | Efficacy and Toxicity of Weekly Carboplatin and Paclitaxel as Induction or Palliative Treatment in Advanced Esophageal Cancer Patients |
Q26852690 | Epidemiological studies of esophageal cancer in the era of genome-wide association studies |
Q33849679 | HLA-DR expression in tumor epithelium is an independent prognostic indicator in esophageal adenocarcinoma patients. |
Q36719828 | Influence of reflux and central obesity on intercellular space diameter of esophageal squamous epithelium |
Q36463755 | Obesity and the Incidence of Upper Gastrointestinal Cancers: An Ecological Approach to Examine Differences across Age and Sex. |
Q36162507 | Pathologic aspects of tumors of gastrointestinal tract in the era of personalized medicine |
Q38674291 | Predicting the Future Burden of Esophageal Cancer by Histological Subtype: International Trends in Incidence up to 2030. |
Q37061705 | Sedation Challenges: Obesity and Sleep Apnea |
Search more.